Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Axillary Reverse Mapping”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableLooking for participantsNCT04665882
What this trial is testing

Nomogram to Predict Breast Cancer Related Lymphedema

Who this might be right for
Breast CancerAxillary Lymph Node DissectionBreast Cancer Related Lymphedema+1 more
Wuhan University 600
Not applicableEnded earlyNCT03428581
What this trial is testing

Preventing Lymphedema in Axillary Lymph Node Dissection

Who this might be right for
LymphedemaBreast CancerMelanoma
Mayo Clinic 264
Testing effectiveness (Phase 2)Study completedNCT01381315
What this trial is testing

Axillary Reverse Mapping

Who this might be right for
Breast Cancer
University of Kansas Medical Center 210
Testing effectiveness (Phase 2)UnknownNCT01038908
What this trial is testing

Breast Lymph Node Mapping

Who this might be right for
Breast Cancer
University of British Columbia 100
Not applicableStudy completedNCT06805240
What this trial is testing

The ILLUMINATE Study

Who this might be right for
Healthy
Laborie Medical Technologies Inc. 90
Early research (Phase 1)Study completedNCT00645541
What this trial is testing

Axillary Reverse Mapping for Invasive Carcinoma of the Breast

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 35
Not applicableWithdrawnNCT04292860
What this trial is testing

Reverse Axillary Mapping in Breast Radiation Treatment Planning

Who this might be right for
Breast CancerLymphedema
UNC Lineberger Comprehensive Cancer Center
Not applicableUnknownNCT03109522
What this trial is testing

Axillary Reverse Mapping (ARM) Technique

Who this might be right for
Invasive Breast CancerDuctal Carcinoma in Situ of the Breast
McMaster University 130
Not applicableStudy completedNCT05040685
What this trial is testing

Axillary Reverse Mapping in Breast Cancer

Who this might be right for
Lymph Node Cancer Metastatic
Hospital Universitari de Bellvitge 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT00572481
What this trial is testing

Axillary Reverse Mapping

Who this might be right for
Cancer of the Breast
University of Arkansas 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT03927027
What this trial is testing

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III
Alliance for Clinical Trials in Oncology 534
Large-scale testing (Phase 3)Study completedNCT01146158
What this trial is testing

Axillary Reverse Mapping for Breast Carcinomas

Who this might be right for
Axillary Dissection
Assistance Publique - Hôpitaux de Paris 210
Not applicableActive Not RecruitingNCT07515300
What this trial is testing

Impact of the ARM Technique on the Prevention of Lymphedema After Axillary Lymphadenectomy: A Multicenter Randomized Clinical Trial

Who this might be right for
Breast CancerLymphedema Arm
Hospital Universitari de Bellvitge 100
Not applicableStudy completedNCT04137744
What this trial is testing

Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection

Who this might be right for
Arm LymphedemaLymphatic Spread of Breast CancerEarly Breast Cancer
Zagazig University 74
Testing effectiveness (Phase 2)Ended earlyNCT01276054
What this trial is testing

Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

Who this might be right for
LymphedemaRecurrent Breast CancerStage IA Breast Cancer+2 more
University of Southern California 4
Not applicableUnknownNCT03333226
What this trial is testing

Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial)

Who this might be right for
Breast Cancer Lymphedema
University Hospital of Ferrara 300
Not applicableStudy completedNCT02994225
What this trial is testing

Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 120